1. Urinary excretion of 3-methylhistidme and creatinine have been measured in normal male and female humans ranging in age from pre-term neonates to 68 years to assess changes in the rate of muscle protein degradation and in muscle mass.
Introduction
The measurement of 3-methylhistidine excretion in urine has recently been recognized as a useful index of 'muscle protein breakdown. The technique is based on evidence that 3-methylhistidine is formed by the post-translational methylation of specific histidine residues in actin and myosin and is excreted quantitatively after degradation of these proteins (Young, Alexis, Baliga, Munro & Muecke, 1972; Long, Haverberg, Young, Kinney, Munro & Geiger, 1975) .
Rates of 3methylhistidine excretion by man have been measured under conditions of undernutrition (Young, Haverberg, Bilmazes & Munro, 1973) , malnutrition (Rao & Nagabhushan, 1973) and trauma (Wannemacher, Dinterman, Pekarek, Bartelloni & Beisel, 1975; Williamson, Farrell, Kerr & Smith, 1977) , but there is little information on 3-methylhistidine excretion by normal humans (Young, Winterer, Munro & Scrimshaw, 1976; Long, Schiller, Blakemore, Geiger, O'Dell & Henderson, 1977) . In many circumstances it is not possible to obtain adequate control samples as a baseline for comparison with abnormal states. Also, in view of the data presented by Young et al. (1976) and. Waterlow, Golden & Picou (1977),
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control values should be obtained from agematched subjects since the rate of 3-methylhistidine excretion and the intensity of total body protein turnover appear to decrease with age.
One of the shortcomings of the 3-methylhistidine technique is the substantial intake of this amino acid in the normal diet where muscle meats are eaten. Since excreted 3-methylhistidine is derived from both dietary and endogenous sources, the use of 3-methylhistidine as an index of muscle protein breakdown is restricted by the necessity for either the accurate monitoring of dietary input or the imposition of a meat-free diet.
We have assessed the contribution of dietary 3-methylhistidine to the urinary 3-methylhistidine output and the time required to clear exogenous 3-methylhistidine from the body after cessation of dietary 3-methylhistidine input. We then measured 3-methylhistidine output by normal healthy humans from the newborn to the elderly. So that the 3-methylhistidine excretion data can be used to calculate the rate of muscle protein degradation, the muscle content of this amino acid has been analysed in a series of muscle samples taken at autopsy from humans of different ages, and the amount of functional muscle mass has been estimated from rates of creatinine excretion (Graystone, 1968) .
Materials and methods

Subjects and diet
Subjects for the urine collection studies were all normal healthy volunteers not receiving any medication. The children participated willingly with the informed consent and supervision of their parents. The subjects consumed a diet free of any muscle protein (henceforth referred to as 'meatfree'), but were required to maintain their protein and energy intakes at previous levels and were advised of the types and quantities of foods which could be eaten in order to achieve this. In this way a meat-free diet was introduced without the drastic change to food habits that would have occurred if a synthetic diet had been administered. In the group of subjects used for the experiment described in Fig. 1 , body weights did not change over 5 days of the meat-free diet.
Pre-term neonates were in the care of staff at the Queen Victoria Hospital, Melbourne, Australia, who kindly provided us with samples from 24 h urine collections. Data only from premature infants in positive nitrogen balance are reported here.
Muscle samples were obtained at autopsy from children and adults who had died suddenly and were free from muscle disease.
Urine collections
Urine was collected into bottles containing either 20 ml of HCl (6 mmol/l) or 1 ml of a saturated solution of thymol in ethanol. At the end of each 24 h collection the urine was either stored in a refrigerator for 1-2 days until sampled or a sample was taken immediately and stored at -1OOC. The total volume was measured at the time of sampling. Urine was usually collected for two consecutive 24 h periods beginning at about 18.00 hours (just before the evening meal). Only single, untimed samples were taken from full-term neonates, but for pre-term neonates analyses were made on several, complete 24 h urine samples per child.
For the analysis of 3-methylhistidine, urine was deproteinized with 3% sulphosalicylic acid, passed through a Millipore filter and applied directly to columns (24 cm x 0.8 cm) containing JEOL LCR-2 resin and maintained at 29OC. The basic amino acids were eluted with trisodium citrate (150 mmol/l; adjusted to pH 4.15 with HCI) at a flow rate of 1.15 ml/min with a JEOL 6AH amino acid analyser. Creatinine was determined by the Technicon Auto-Analyzer method N116.
Muscle samples
Samples from the left vastus lateralis muscle were processed as described by Haverberg, Omstedt, Munro & Young (1975) . The hydrolysates were dried under vacuum at 4SoC, desalted on a column of Dowex-50 as described by Tomas, Munro & Young (1979) , made up to volume with water and analysed as for urine except the elution buffer was pH 4.27 and the flow rate was 0.61 ml/min. Myofibrillar and sarcoplasmic proteins were separated as described by Haverberg, Munro & Young (1974) and then processed and analysed in a similar way to total protein.
Values were given as mean f 1 SEM.
Results
Diet and urinary 3-methylhistidine
Urine was collected from six male subjects aged 28-36 years and weighing 60-84 kg for 5 consecutive days during consumption of a normal meat-containing diet and for a further 5 con- 
3-Methylhistidine and creatinine in untimed urine samples
Two female and two male subjects between 19 and 38 years of age who were eating a meat-free diet collected urine samples from each micturition over a 2-3 day period. The relationship between the 3-methylhistidine and creatinine concentrations in each of these samples is shown in Fig. 4 . The two components are closely related, especially at creatinine concentrations below 20 pmol/ml. At higher creatinine concentrations (urine flows less than about 0.5 ml/min) obtained in only two subjects, the correlation deteriorated but the average slope was unaltered whether or not these data (five samples) were included in the calculated regression (for n = 48, y = 0 . 0 1 9 2~ -0.0010, r = 0.96; for n = 43, y = 0 . 0 1 8 7~ -0.0006, r = 0.98).
3-Methylhistidine concentration in muscle
The concentration of 3-methylhistidine in muscle protein is shown in Table 1 . For subjects aged 4-65 years, the mean content of 3-methylhistidine in total mixed muscle protein was 3.63 f 0.06 pmol/g and the mean content of protein in muscle was 204 f 8.0 mg/g wet weight. In several samples myofibrillar and sarcoplasmic proteins were separated before analysis. No 3-methylhistidine was detected in the sarcoplasmic fractions.
Discussion
Although a change in the rate of 3-methylhistidine excretion indicates a change in the breakdown rate of myofibrillar protein (Young et al., 1976) , it is not always possible to measure the rates of excretion in the same individual before and after the onset of an abnormal state. For example, to assess whether trauma, by either physical or thermal injury, has affected the rate of protein breakdown of muscle, comparison must be made with a sample population of matched, normal controls. We find that there is a progressive decline in the rate of 3-methylhistidine excretion per unit creatinine output from pre-term neonates of 24-30 weeks gestational age to young adults of about 17 years of age. Young et al. (1976) measured the 3-methylhistidine output in neonates, young adults and elderly people. These authors found a lower rate of excretion of 3-methylhistidine relative to body weight and to creatinine output in adults compared with neonates, in agreement with our findings. However, their average values are about 15-20% lower than ours. We have no explanation for the lower mean values reported by Young et al. (1976) but the degree of variability and overlap in the two studies is notable. Long et al. (1977) found an even higher degree of variability in the 3-methylhistidine excretion per unit body weight of 12 normal adults but details of diet and creatinine excretion were not reported. Nevertheless the excretion rates of 3.63 0.48 for adult women and 3-97 5 0.76 pmol day-' kg-' for adult men are similar to our values. Rates of excretion by four normal Indian children aged between 1 and 5 years were reported by Rao & Nagabhusan (1973) to be from 1.25 to 2.5 pmol day-' kg-'. These values are lower than we would expect from Fig. 3 , but we did not study a comparable age group. Rao & Nagabhusan (1973) did not relate 3-methylhistidine output to creatinine excretion.
In addition to these measurements on human subjects muscle protein breakdown is more rapid in weanling rats than in older animals (Millward, Garlick, Stewart, Nnanyelugo & Waterlow, 1975) . The fall may therefore be a general phenomenon which coincides with a reduction in protein synthesis rates with age in both man and experimental animals (Young, Steffee, Pencharz, Winterer & Scrimshaw, 1975; Millward et al., 1975) .
The importance of dietary muscle as a source of urinary 3-methylhistidine is clearly shown in Table  1 and illustrates the crucial need to specify the diet whenever 3-methylhistidine data are presented. There appears to be no easy way to monitor and adjust for the dietary contribution of 3-methylhistidine, and hence elimination of meat from the diet for a period of at least 3 days before urine collection seems the most satisfactory procedure. The rate of creatiniine excretion can be used as an index of muscle mass with 1 g/day arising from 20 kg of muscle (Graystone, 1968) . If the daily excretion of 3-methylhistidineY its concentration in muscle protein, the protein content of muscle and the creatinine excretion are known, the total rate of breakdown of muscle protein can be calculated. Several workers have used this approach for humans (Young et Asatoor & Armstrong (1967) for the 3-methylhistidine content of muscle. Asatoor & Armstrong (1967) found calf muscle protein from an adult man to contain 1.76 pmol of 3-methylhistidine/g. This is about half the value that we have found in human muscle (Table 1) . Use of the lower value considerably overestimates the contribution of muscle to total nitrogen excretion or to total body protein turnover. Wannemacher et al. (1975) , however, estimated the 3-methylhistidine content of contractile fibres from the analytical data available for actin and myosin. When their estimate is related to total muscle protein it agrees reasonably well with our direct .analyses. Since this paper was submitted for publication similar values to our own for infant and adult muscles (mostly psoas) have been published (Bilmazes, Uauy, Haverberg, Munro & Young, 1978) but they did not present data for children between 14 months and 19 years old, such as the results in Table 1 .
On the basis of our data, the average fractional degradation rate of muscle protein in adults is 1.10 & O.O2%/day. For adult males of 70 kg body weight and creatinine excretion 0.24 mmol day-' kg-', this degradation rate is equivalent to 83 g of muscle protein/day. However, these rates may slightly underestimate total protein turnover in view of the evidence that sarcoplasmic proteins turn over faster than do myofibrillar proteins (Millward, 1970; Halliday & McKeran, 1975) .
The lower concentrations of 3-methylhistidine in muscle from neonates relative to children and adults may be due either to a lower proportion of myofibrillar protein in the total mixed muscle protein, which includes non-contractile cells, or to the presence of non-methylated myosin. Myosin from foetal rabbits, rats, mice and hamsters is not methylated (Trayer, Harris & Perry, 1968; Helm, Dehl & Vancikova, 1977) and since myosin contributes about 20-30% of total muscle 3-methylhistidine (Haverberg, Munro & Young, 1974; Wannemacher et al., 1975) , a similar occurrence in humans may account for much of the difference observed. However, the lower protein/DNA ratios in muscles of foetuses and newborn humans (Widdowson, 1974) suggests that a lower relative abundance of contractile protein would also contribute to this effect. Analyses of myosin purified from muscles of human foetuses or neonates is required to establish the extent of any difference.
It is recognized that the rate of creatinine excretion is not precisely constant (Peters, 1973) and may be affected by diet (Wood, Schneeman, Zezulka, Calloway & Margen, 1976) . However, the fact that creatinine and 3-methylhistidine are each specifically associated with functional muscle mass renders the 3-methylhistidine/creatinine excretion ratio, which is in effect a measure of the fractional degradation rate of myofibrillar protein, of particular interest. It is also evident from Fig. 4 that analysis of a single urine sample would detect most meaningful deviations in the 3-methylhistidine excretion rate. The degree of variation in the daily 3-methylhistidine/creatinine ratio between subjects (Fig. 2) is about the same as the variation of this ratio between single untimed urine samples collected from one subject (coefficient of variation about 10%) and is thus a limiting factor in assessing deviation from normal for an individual. Since creatinine excretion increases markedly during fever (Long et al., 1977; Wannemacher et al., 1975) it should not be assumed to be constant during acute stress and should also be assessed in patients with muscle disease or hormone imbalance, to ensure the validity of comparisons with control subjects.
We conclude that the measurement of the urinary excretion of 3-methylhistidine under carefully controlled conditions can provide a reproducible index of the rate of myofibrillar protein breakdown within an individual, and the normal ranges described facilitate assessment of this index when more direct control data are unavailable.
